Literature DB >> 29049863

Reply to: Medication contaminants as a potential cause of anaphylaxis to vincristine: What about drug specific antigens?

David A Hill1,2, Allison Barz Leahy3, Joseph Sciasci4, Sean P O'Neill5, Anne Reilly3, Naomi Balamuth3, Steven H Seeholzer6, Jonathan M Spergel1,2, Terri F Brown-Whitehorn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29049863      PMCID： PMC5739934          DOI： 10.1002/pbc.26868

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  10 in total

1.  Drug allergy: an updated practice parameter.

Authors: 
Journal:  Ann Allergy Asthma Immunol       Date:  2010-10       Impact factor: 6.347

2.  Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy.

Authors:  Lisa M Wheatley; Marshall Plaut; Julie M Schwaninger; Aleena Banerji; Mariana Castells; Fred D Finkelman; Gerald J Gleich; Emma Guttman-Yassky; Simon A K Mallal; Dean J Naisbitt; David A Ostrov; Elizabeth J Phillips; Werner J Pichler; Thomas A E Platts-Mills; Jean-Claude Roujeau; Lawrence B Schwartz; Lauren A Trepanier
Journal:  J Allergy Clin Immunol       Date:  2015-08       Impact factor: 10.793

3.  Cetirizine-induced anaphylaxis: a rare adverse drug reaction.

Authors:  Nisha Afonso; Pankaj Shetgaonkar; Amit Dang; Padmanabh V Rataboli
Journal:  Br J Clin Pharmacol       Date:  2009-02-23       Impact factor: 4.335

4.  Medication contaminants as a potential cause of anaphylaxis to vincristine: What about drug-specific antigens?

Authors:  Nicholas G Kounis; Ioanna Koniari; George Soufras; Emmanouil Chourdakis; Anastasios Roumeliotis; Nicholas Patsouras; George Hahalis
Journal:  Pediatr Blood Cancer       Date:  2017-10-14       Impact factor: 3.167

5.  [Myocardial infarction induced by vincristine in patients with Hodgkin's lymphoma. Description of 2 cases and review of the literature].

Authors:  M Barra; M Brignole; B Sartore; A Bertulla
Journal:  G Ital Cardiol       Date:  1985-01

Review 6.  Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management.

Authors:  Nicholas G Kounis
Journal:  Clin Chem Lab Med       Date:  2016-10-01       Impact factor: 3.694

7.  Vincristine-induced myocardial infarction.

Authors:  E M Mandel; U Lewinski; M Djaldetti
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

8.  Prospective epidemiological study of the prevalence of human leukocyte antigen (HLA)-B*5701 in HIV-1-infected UK subjects.

Authors:  C Orkin; S T Sadiq; L Rice; F Jackson
Journal:  HIV Med       Date:  2009-09-24       Impact factor: 3.180

Review 9.  Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.

Authors:  Ursula Amstutz; Neil H Shear; Michael J Rieder; Soomi Hwang; Vincent Fung; Hidefumi Nakamura; Mary B Connolly; Shinya Ito; Bruce C Carleton
Journal:  Epilepsia       Date:  2014-03-05       Impact factor: 5.864

10.  HLA-B*5701 screening for hypersensitivity to abacavir.

Authors:  Simon Mallal; Elizabeth Phillips; Giampiero Carosi; Jean-Michel Molina; Cassy Workman; Janez Tomazic; Eva Jägel-Guedes; Sorin Rugina; Oleg Kozyrev; Juan Flores Cid; Phillip Hay; David Nolan; Sara Hughes; Arlene Hughes; Susanna Ryan; Nicholas Fitch; Daren Thorborn; Alastair Benbow
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.